50% off Premium Yearly

TSE:HMMJ
This summary was created by AI, based on 1 opinions in the last 12 months.
Horizon’s Medical Marijuana (HMMJ-T) has garnered attention from experts due to its potential growth, especially if upcoming banking legislation is passed. There seems to be a belief in bipartisan support for this legislative change, which could significantly benefit the company. Despite the inherent volatility associated with medical marijuana stocks, the current sentiment is optimistic. Analysts suggest that HMMJ-T has the potential for substantial returns, classifying it as a strong candidate for significant gains, often referred to as a '2-bagger,' '4-bagger,' '5-bagger,' or perhaps even a '10-bagger.' This indicates that there is considerable excitement and hope for the stock's future performance among market experts.
Good time to get in? His firm uses only ETFs. This is an example of where ETFs are not the way to go on themes. All the enthusiasm about marijuana is already baked in, so could sell off once it’s legal. Canopy Growth is the Phillip Morris of marijuana. Why pay the premium of the ETF, just buy Canopy Growth.
Baytex versus HMMJ. There is no correlation between these two. BTE-T looks fine technically as he thinks WTI should return back above $70 before year end. The recent breakout is positive, especially since it was basing around $3.50. He does not understand the cannabis market, so can’t render an opinion. “You can’t make an iPhone in your basement, but you can grow marijuana.” He thinks demand is already met, so he would only hold a small lot of HMMJ-T to talk about at cocktail parties.
This ETF is better than holding any individual company as it offers better diversification including some of the smaller producers. His view that these niche sector ETFs should be viewed as a speculative holding as many of the holdings are not even showing positive earnings yet. MER is 0.75%. It is a little early to consider this as a long term holding.
It is 100% speculative. You have to be ready for a bumpy ride. We saw a big M&A transaction today and you will see a lot more of them. There will be a handful of survivors. This is incredibly overvalued today. If the US went for legal weed use, it would be a game changer. Wait until it is a value play after the next recession.
Marijuana. If you are going to play the sector it is a momentum trade and the ETF is the way to go. The sector is tremendously ahead of itself and there is a lot of speculation in these stocks. We will not know for a year after it becomes legal, how these companies are going to do. You could get a lot of price volatility.
You have to remember, this ETF and the companies in it, none are making any money. Secondly, we don't know what price this is going to come out at or the distribution network. We don't know what the margins of profit are going to be. On that basis, he won't buy this. He is an investor, not a gambler. If you wouldn't take your money to a gambling casino, then don't put it in this stock.
Very dubious about the whole marijuana sector. It's an area where you can sort of put your sign up saying we are now in the marijuana business, and away you go. There are some big legitimate companies that are going to do well, but we really don't know exactly how well they are going to do. He is not sure they will be very profitable.
There is a lot of emerging names in the marijuana space. It is very tricky, because we are still in early days in the marijuana market. It’s hard to tell who is going to be the winner and who is going to be the loser, so owning the ETF is probably the right way to go. The stock can be volatile, so if you have the stomach for it and you feel it is an area you can feel confident about, you are probably better off playing this then picking an individual producer or 2.
Marijuana. The ETF gives you the basket of securities. When you go into an area that is new, you are never going to buy these stocks cheap. We had high momentum and now it seems to have broken down. You have to manage risk carefully. Have a stop loss.